C-kit Asp-816-Val Mutation Analysis in Patients with Mastocytosis
Authors:
- R. HeideRHR. Heide
- A.P. OranjeAOA.P. Oranje
- R.H.N. van SchaikRSR.H.N. van Schaik
- 1 December 2006
- journal article
- Published by S. Karger AG in Dermatology
- Vol. 214 (1) , 15-20
Abstract
Background:Mastocytosis is a heterogeneous group of disorders characterized by abnormal accumulation of mast cells. Objective: Skin biopsies from 24 patients (23 with proven mastocytosis) were screened for the presence of the c-kit Asp-816-Val mutation. Methods: In frozen biopsies, RNA was isolated, cDNA synthesis and PCR, the expected PCR product of 346 bp was obtained from 23 patients. Results:In patients with urticaria pigmentosa, the mutation was detected in 38% of the adults and 25% of the children. With regard to the clinical presentation of the disease, no difference was found between adult patients with and without the mutation, as detected with our assay. One out of the 2 children with the mutation had an atypical presentation of the disease. Conclusion: the mutation could not be detected in all the patients, probably due to lack of sensitivity of the methods.Keywords
This publication has 14 references indexed in Scilit:
- Neonatal Mastocytosis with Pachydermic Bullous Skin without c-Kit 816 MutationDermatology, 2005
- Mastocytosis: Pathology, genetics, and current options for therapyLeukemia & Lymphoma, 2005
- Cutaneous mastocytosis in children: a clinical analysis of 71 casesJournal of the European Academy of Dermatology and Venereology, 2004
- One-Step Detection of c-kit Point Mutations Using Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping and Hybridization ProbesThe American Journal of Pathology, 2003
- Kit and c-kit Mutations in Mastocytosis: A Short Overview with Special Reference to Novel Molecular and Diagnostic ConceptsInternational Archives of Allergy and Immunology, 2002
- Diagnostic criteria and classification of mastocytosis: a consensus proposalLeukemia Research, 2001
- NEW APPROACHES TO THERAPY FOR MASTOCYTOSIS: A Case for Treatment With kitKinase InhibitorsHematology/Oncology Clinics of North America, 2000
- Indolinone Derivatives Inhibit Constitutively Activated KIT Mutants and Kill Neoplastic Mast CellsJournal of Investigative Dermatology, 2000
- Identification of Activating c-kit Mutations in Adult-, but not in Childhood-Onset Indolent Mastocytosis: A Possible Explanation for Divergent Clinical BehaviorJournal of Investigative Dermatology, 1998
- Cutaneous Mastocytosis in AdultsDermatology, 1998